Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allergan CEO resigns from Edwards Lifesciences' board
Yahoo/Reuters
Saturday, October 4, 2014 - 9:47am
tags:
Allergan, Edwards Lifesciences
Endo Accused of Conspiring to Delay Generic Version of Opana
Bloomberg
Saturday, October 4, 2014 - 9:43am
tags:
Endo, Opana, generics
Baxter Gets Shot In The Arm From Rockwell Deal
Investor's.com
Saturday, October 4, 2014 - 9:41am
tags:
Baxter, Rockwell Medical
Genentech Sales Reps Face Hospital Bans Over a Wholesale Change
WSJ Pharmalot
Friday, October 3, 2014 - 7:32pm
tags:
Genentech, drug reps, hospitals, distribution
Allergan Tips to Valeant in Deal Chain Reaction: Real M&A
Bloomberg
Friday, October 3, 2014 - 4:43pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
OxyContin, Cialis Makers Dodge Court to Beat Patent Suits
Bloomberg
Friday, October 3, 2014 - 4:41pm
tags:
oxycontin, Cialid, patents, Hatch Waxman Act, Purdue Pharma
Medtronic Has A New Plan To Finance Covidien Acquisition
Bidness Etc.
Friday, October 3, 2014 - 4:31pm
tags:
Medtronic, Covidien, M&A, devices
MannKind Receives $150 Million Upfront Payment from Sanofi
Yahoo/Zacks.com
Friday, October 3, 2014 - 4:28pm
tags:
MannKind, Sanofi, Afrezza
Boston Scientific Mesh Verdict Halved by Judge to $34 Million
Bloomberg
Friday, October 3, 2014 - 4:25pm
tags:
Boston Scientific, devices, pelvic mesh
Some ETFs Saying a Salix Takeover Could be Afoot
Yahoo/ETFTrends
Friday, October 3, 2014 - 4:24pm
tags:
Salix, M&A, Actavis
Luminex xTAG GPP for Gastroenteritis Gets FDA Clearance
Yahoo/Zacks.com
Friday, October 3, 2014 - 4:23pm
tags:
Luminex, xTAG GPP, FDA, gastroenteritis, diagnostics, ebola virus
Top 10 pharma companies by number of employees - 2014
Fierce Pharma
Friday, October 3, 2014 - 10:18am
tags:
pharma employees
Why Allergan Inc. Is an Activist Investor Target
Motley Fool
Friday, October 3, 2014 - 10:10am
tags:
Allergan, investors
NewLink, Inovio And Hemispherx Still Strong On US Ebola Scare
Bidness Etc.
Friday, October 3, 2014 - 10:02am
tags:
NewLink Genetics, Inovio, Hemispherx Biopharma, ebola virus
DaVita's Acquisitions Look Promising, High Debt a Concern
Yahoo/Zacks.com
Friday, October 3, 2014 - 10:00am
tags:
DaVita, M&A, dialysis
Merck Gardasil follow-up could block 90% of cervical cancers--if uptake improves, that is
Fierce Vaccines
Friday, October 3, 2014 - 9:58am
tags:
Merck, Gardasil, HPV, cervical cancer, vaccines, 9-valent HPV vaccine
Infographic: FDA Warning Letters Have Increased Substantially Since 2007; Expected To Increase Again In 2015
CP Wire
Friday, October 3, 2014 - 9:43am
tags:
FDA, warnings
Titan Pharmaceuticals Announces Pricing of Public Offering
Yahoo
Friday, October 3, 2014 - 8:51am
tags:
Titan Pharmaceuticals, IPOs
One Doc Shoulders Aside Criticism of Sunshine Database Payment
WSJ Pharmalot
Friday, October 3, 2014 - 8:05am
tags:
Physician Payment Sunshine Act, devices
Exclusive: Facebook plots first steps into healthcare
Yahoo/Reuters
Friday, October 3, 2014 - 7:58am
tags:
Facebook, social media, patients

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.